A recent study reveals oscillations in the refractive index that are faster than can be explained by current theories.
A study recently published in the journal Nanophotonics reveals that by rapidly modulating the refractive index – which is the ratio of the speed of electromagnetic radiation in a medium compared to its speed in a vacuum – it’s possible to produce photonic time crystals (PTCs) in the near-visible part of the spectrum.
The study’s authors suggest that the ability to sustain PTCs in the optical domain could have profound implications for the science of light, enabling truly disruptive applications in the future.
PTCs, materials in which the refractive index rises and falls rapidly in time, are the temporal equivalent of photonic crystals in which the refractive index oscillates periodically in space causing, for example, the iridescence of precious minerals and insect wings.

Experimental setup for measuring time-refraction in the single-cycle regime. Credit: Eran Lustig et al.
A PTC is only stable if the refractive index can be made to rise and fall in line with a single cycle of electromagnetic waves at the frequency concerned so, unsurprisingly, PTCs have thus far been observed at the lowest-frequency end of the electromagnetic spectrum: with radio waves.
In this new study, lead author Mordechai Segev of the Technion-Israel Institute of Technology, Haifa, Israel, with collaborators Vladimir Shalaev and AlexndraBoltasseva from Purdue University, Indiana, USA, and their teams, sent extremely short (5-6 femtosecond) pulses of laser light at a wavelength of 800 nanometers through transparent conductive oxide materials.
This caused a rapid shift in refractive index that was explored using a probe laser beam at a slightly longer (near infrared) wavelength. The probe beam was rapidly red-shifted (that is, its wavelength increased) and then blue-shifted (wavelength decreased) as the material’s refractive index relaxed back to its normal value.

Transmission spectrograms of 44 fs probe pulses that have passed through the ITO sample, for modulator pulses of different temporal widths. Credit: Eran Lustig et al.
The time taken for each of these refractive index changes was minuscule – less than 10 femtoseconds – and, therefore, within the single cycle necessary to form a stable PTC.
“Electrons excited to high energy in crystals generally need over ten times as long to relax back to their ground states, and many researchers thought that the ultra-fast relaxation we observe here would be impossible,” Segev said. “We don’t yet understand exactly how it happens.”
Co-author Shalaev further suggests that the ability to sustain PTCs in the optical domain, as demonstrated here, will “open a new chapter in the science of light and enable truly disruptive applications”. However, we know as little of what these might be as physicists in the 1960s knew of the possible applications of lasers.
Reference: “Time-refraction optics with single cycle modulation” by Eran Lustig, Ohad Segal, Soham Saha, Eliyahu Bordo, Sarah N. Chowdhury, Yonatan Sharabi, Avner Fleischer, Alexandra Boltasseva, Oren Cohen, Vladimir M. Shalaev and Mordechai Segev, 31 May 2023, Nanophotonics.
DOI: 10.1515/nanoph-2023-0126
The research was funded by the German Research Foundation.
News
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
This Deadly Disease Was Wiping Out Humans 5,500 Years Ago
A new study suggests plague was already a deadly threat 5,500 years ago, striking small hunter-gatherer communities long before cities and agriculture emerged. For centuries, plague has been remembered as the disease that devastated [...]
China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new [...]
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]















